Unknown

Dataset Information

Prospective alpha allocation in the Clarification of Optimal Anticoagulation through Genetics (COAG) trial.


ABSTRACT:

Background

The Clarification of Optimal Anticoagulation through Genetics (COAG) trial is a large, multicenter, double-blinded, randomized trial to determine whether use of a genotype-guided dosing algorithm (using clinical and genetic information) to initiate warfarin treatment will improve anticoagulation status when compared to a dosing algorithm using only clinical information.

Purpose

This article describes prospective alpha allocation and balanced alpha allocation for the design of the COAG trial.

Methods

The trial involves two possibly heterogeneous populations, which can be distinguished by the difference in warfarin dose as predicted by the two algorithms. A statistical approach is detailed, which allows an overall comparison as well as a comparison of the pri

SUBMITTER: Joo J 

PROVIDER: S-EPMC3111931 | biostudies-literature | 2010 Oct

REPOSITORIES: biostudies-literature